Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study

Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study

The PT-Cy was considered as one of the mainstay protocol for graft verus host disease (GVHD) prophylaxis. Recent study demonstrated that PT-Cy combined with other immunosuppressants could further reduce the incidence of GVHD and improve the GVHD and relapse free survival (GRFS). In this prospective...

Full description

Bibliographic Details
Main Authors: Jie-ling Jiang, Wen-hui Gao, Li-ning Wang, Ming Wan, Ling Wang, Jiong Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Medicine
Subjects:
allogeneic peripheral stem cell transplantation
graft vs. host disease
post-transplantation cyclophosphamide
lymphoid malignancies
anti-thymoglobulin
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.630160/full

Similar Items

Similar Items